Endotoxin, the lipopolysaccharide component of the Gram-negative bacterial cell wall, is a key factor in the pathogenesis of the systemic inflammatory processes that may occur following major surgery. Natural levels of immunity to endotoxin in the form of IgG and IgM anti-endotoxin core antibodies (EndoCAb) are variable. Over the past 6 years, we have carried out 5 clinical studies on nearly 1500 surgical patients and have repeatedly demonstrated a relationship between low baseline EndoCAb levels and poor outcome. In these studies, we have noticed an apparent variation between baseline levels of IgG EndoCAb in US surgical patients and the reference range from 1000 Scottish blood donors. 1,2 We, therefore, decided to examine all our data systematically.
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In all of the studies, pre-operative IgG and IgM EndoCAb levels were determined using an identical standard ELISA technique developed by Barclay and coworkers. 2 All the blood samples were collected in glass tubes without additive and centrifuged for 10 min at 2000 g and serum was stored at between -20°C and -70°C until assayed. IgG EndoCab and IgM EndoCab levels were measured in each group by enzyme-linked immunosorbant assay (ELISA). For this, incomplete-core rough mutant lipopolysaccharide from each of 4 species of Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Klebsiella aerugenes, and Salmonella typhimurium) were complexed with polymixin B and coated on polystyrene microplates. IgG EndoCAb and IgM EndoCAb concentrations were determined with alkaline phosphatase-conjugated antibodies specific for human gammaglobulin y and m heavy chains. Test sera were compared to a reference serum calibrated in EndoCAb median units (MU) where 100 is the median value for 1000 healthy adult blood donors. 1 These healthy blood donors served as our control group. The results are displayed in Figure 1 .
Median EndoCAb levels were compared using a Mann-Whitney test. The IgG EndoCAb of the UK surgical patients was not significantly different from the UK control group (median, 85 MU; 95% CI 19-696 versus median, 100 MU; 95% CI, 26-324; P = 0.68). The US surgical group, however, had a significantly higher IgG EndoCAb than both the control group (median, 248 MU; 95% CI, 65-790 versus median, 100 MU, P < 0.0001) and the UK surgical patients (median, 248 MU versus 85 MU, P < 0.0001)
The IgM EndoCAb of the UK surgical patients was significantly lower than the UK control group (median, 79 MU; 95% CI, 22-204 versus 100 MU; 95% CI, 28-340; P = 0.0004). The IgM EndoCAb of the US surgical patients was significantly higher than both the UK control group (median, 139 MU; 95% CI, 23-576 versus 100 MU, P < 0.0001) and the UK surgical patients (median, 139 MU versus 79 MU; P < 0.0001). The magnitude of difference between the groups was less for IgM EndoCAb than IgG EndoCAb. The reasons for this difference are at present unknown but the following are possible explanations.
The difference found in our groups may be coincidental
and not representative of the population as a whole. To confirm or refute this, a further prospective study is required.
2. Inconsistency in the methodology of assay measurement. This is unlikely, as all ELISA testing was performed in the UK in a standard fashion by our group. However, the US samples required storage and transportation to the UK in order to be analysed and this may have caused degradation of the sample. This is unlikely because the samples were shipped frozen on dry ice and, if it were the case, one would expect the US EndoCAb levels to be lower than those from the UK. If, however, degradation does occur it appears that the ensuing error is systematic as low EndoCAb levels measured in the US surgical patients remained independent predictors of poor outcome. We are at present investigating the effect of storage and transfer on EndoCAb levels measured by ELISA technique.
3. Differences in the systems of health care in the two countries may also influence EndoCAb levels. In the US, the length of time from acute illness (e.g. myocardial infarction) and invasive investigation (e.g. angiography)
to surgery is significantly shorter then in the UK. This means that US patients may have raised levels of EndoCAb at the time of surgery in response to recent acute events where as UK patients are back to original chronic levels.
4. The two groups have different underlying disease processes. The groups are not matched in this respect, and this also could affect the EndoCAb levels. There may be significant genetic differences between the UK and the US populations. The US population is from a more diverse and migrant ethnic base. This introduces the potential for natural selection added to the inherent differences between races.
5.
Environmental factors may be influential. Diet, pollution, smoking and alcohol could all be significantly different between the groups and their effects on EndoCAb levels are at the present time unknown.
CONCLUSIONS
This retrospective study compared baseline EndoCAb IgG and IgM levels of healthy volunteers with the pre-operative levels of UK and US surgical patients. It showed that in our groups US surgical patients had higher IgG (and to a lesser extent IgM) EndoCAb levels than healthy volunteers and UK surgical patients. The reasons for this are not at present clear. However, we know that low levels of EndoCAb preoperatively are an independent predictor of poor postoperative outcome. We, therefore, suggest this warrants further investigation. 
